A precise temperature control during hyperthermic intraperitoneal chemotherapy: Does it promise an early return of bowel function?

Date 28 June 2017
Event ESMO World Congress on Gastrointestinal Cancer 2017
Session ESMO World Congress on Gastrointestinal Cancer 2017
Topics Gastrointestinal Cancers
Palliative and Supportive Care
Presenter Jinning Ye
Citation Annals of Oncology (2017) 28 (suppl_3): iii13-iii136. 10.1093/annonc/mdx261
Authors J. Ye, J. Xu, J. Peng, Y. HE, W. Song
  • /


The hyperthermic intraperitoneal chemotherapy (HIPEC) has been widely accepted as a useful palliative treatment for peritoneal carcinomatosis due to advanced malignances. Perfusion temperature is a vital factor determining the efficacy of HIPEC, but can be apparently fluctuant. This study was designed to investigate whether a precise temperature control could enhance bowel recovery after palliative surgery.